Park; John Edward
Patent Applications and Registrations
Patent applications and USPTO patent grants for Park; John Edward.The latest application filed is for "medicaments for the treatment or prevention of fibrotic diseases".
- Park; John Edward - Warthausen DE
- PARK; John Edward - Biberach DE
- Park, John Edward - Biberach/Riss DE
| Patent | Date |
|---|---|
| Medicaments For The Treatment Or Prevention Of Fibrotic Diseases App 20200330435 - Park; John Edward ; et al. | 2020-10-22 |
| Recombinant Rhabdovirus Encoding For Ccl21 App 20200237838 - MUELLER; Philipp ; et al. | 2020-07-30 |
| Medicaments For The Treatment Or Prevention Of Fibrotic Deiseases App 20190038600 - Park; John Edward ; et al. | 2019-02-07 |
| Medicaments for the treatment or prevention of fibrotic diseases Grant 10,154,990 - Park , et al. Dec | 2018-12-18 |
| Medicaments For The Treatment Or Prevention Of Fibrotic Diseases App 20160136133 - Park; John Edward ; et al. | 2016-05-19 |
| Anticoagulant Antidotes App 20150210778 - VAN RYN; Joanne ; et al. | 2015-07-30 |
| Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds Grant 9,034,822 - Van Ryn , et al. May 19, 2 | 2015-05-19 |
| Medicaments For The Treatment Or Prevention Of Fibrotic Diseases App 20140296217 - PARK; John Edward ; et al. | 2014-10-02 |
| Medicaments For The Treatment Or Prevention Of Fibrotic Diseases App 20140128409 - PARK; John Edward ; et al. | 2014-05-08 |
| Anticoagulant Antidotes App 20130289248 - VAN RYN; Joanne ; et al. | 2013-10-31 |
| Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds Grant 8,486,398 - Van Ryn , et al. July 16, 2 | 2013-07-16 |
| Anticoagulant Antidotes App 20120027780 - Van Ryn; Joanne ; et al. | 2012-02-02 |
| Medicaments For The Treatment Or Prevention Of Fibrotic Diseases App 20120004202 - PARK; John Edward ; et al. | 2012-01-05 |
| Compounds For The Treatment Of Proliferative Processes App 20110076238 - PARK; John Edward ; et al. | 2011-03-31 |
| Medicaments For The Treatment Or Prevention Of Fibrotic Diseases App 20100204211 - PARK; John Edward ; et al. | 2010-08-12 |
| Medicaments For The Treatment Or Prevention Of Fibrotic Diseases App 20090048267 - PARK; John Edward ; et al. | 2009-02-19 |
| Medicaments for the Treatment or Prevention of Fibrotic Diseases App 20060154939 - Park; John Edward ; et al. | 2006-07-13 |
| Medicaments for the Treatment or Prevention of Fibrotic Diseases App 20060148883 - Park; John Edward ; et al. | 2006-07-06 |
| Medicaments for the Treatment or Prevention of Fibrotic Diseases App 20060142373 - Park; John Edward ; et al. | 2006-06-29 |
| Compounds for the treatment of proliverative processes App 20060030579 - Park; John Edward ; et al. | 2006-02-09 |
| FAP-activated anti-tumor prodrugs App 20040033957 - Patzelt, Erik ; et al. | 2004-02-19 |
| FAP-activated anti-tumor compounds App 20030232742 - Peters, Stefan ; et al. | 2003-12-18 |
| FAP-activated anti-tumor compounds App 20030211979 - Blech, Stefan ; et al. | 2003-11-13 |
| FAPalpha -specific antibody with improved producibility App 20030143229 - Park, John Edward ; et al. | 2003-07-31 |
| FAP-activated anti-tumor compounds App 20030055052 - Peters, Stefan ; et al. | 2003-03-20 |
| FAP-activated anti-tumor compounds App 20020155565 - Garin-Chesa, Pilar ; et al. | 2002-10-24 |
| FAP.alpha.-specific antibody with improved producibility Grant 6,455,677 - Park , et al. September 24, 2 | 2002-09-24 |
| Human FAP-alpha-specific antibodies App 20020099180 - Pfizenmaier, Klaus ; et al. | 2002-07-25 |
| Fapalpha-specific Antibody With Improved Producibility App 20020052480 - PARK, JOHN EDWARD ; et al. | 2002-05-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 